A case-control study on the influence of glycolipid GM3 in glomerular disease

A case-control study on the influence of glycolipid GM3 in glomerular disease - GM3 in glomerular disease study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032074

Enrollment

230

Registered

2018-04-10

Start date

2018-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glomerular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diseased: Patients diagnosed with renal biopsyin in Kitasato university hospital, division of nephrology(2010/1/1-2015/12/31) a) MCNS, b) FSGS, c) IgA-nephritis, d) Membrane nephritis, e) DM-N 2) control Nephrectomy patients who assent in Kitasato University Hospital, Division of Urology (2018/4/1-2020/12/31). age: 20-75 ages

Exclusion criteria

Exclusion criteria: Participation refusal from principal or agent

Design outcomes

Primary

Measure	Time frame
proteinuria, renal function after 2 years of renal biopsy	—

Countries

Japan

Contacts

Public ContactSHOKICHI NAITO

KITASATO UNIVERSITY HOSPITAL DIVISION OF NEPHROLOGY

snaito@med.kitasato-u.ac.jp042-778-8111

Outcome results